PASSERI DANIEL R
SEC CIK 1190121 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CUE | Cue Biopharma, Inc. | CEO, Dir | 164.6K | $89.5K | — | 8 | 2021-09-24 | 2024-12-16 |
Most active insiders at CUE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lin Shao-Lee | CEO, Dir | — | $1.61M |
| 2 | Ray Sumita | Chief Legal Compliance Off, Corp. Sec | — | $265.6K |
| 3 | Meluzio Michael Vincent | VP, Prin. Accounting Off | — | $169.3K |
| 4 | Sarraf Pasha | Dir | $99.7K | — |
| 5 | Meehan Viola Mong | Dir | — | — |
| 6 | Borie Dominique Christian | Chief Medical Off, Head of Research, Development | — | — |
| 7 | Garzone Pamela | Dir | — | — |
| 8 | Camardo Daniel A. | Dir | — | — |
| 9 | Ahlers James M | CFO | — | — |
PASSERI DANIEL R made no open-market trades at CUE in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-18 | 2024-12-16 | CUE | Cue Biopharma, Inc. | PASSERI DANIEL R | CEO, Dir | P - Purchase | $1.03 | +30.0K | 164.6K | +22% | +$30.9K | |
| 2023-08-16 | 2023-08-14 | CUE | Cue Biopharma, Inc. | PASSERI DANIEL R | CEO, Dir | P - Purchase | $2.86 | +3,000 | 134.6K | +2% | +$8,580 | |
| D | 2022-04-04 | 2022-03-31 | CUE | Cue Biopharma, Inc. | PASSERI DANIEL R | CEO, Dir | F - Tax | $4.88 | -32.1K | 141.6K | -18% | -$156.8K |
| D | 2022-04-04 | 2022-03-31 | CUE | Cue Biopharma, Inc. | PASSERI DANIEL R | CEO, Dir | G - Gift | $0.00 | -10.0K | 131.6K | -7% | $0 |
| D | 2022-04-04 | 2022-03-31 | CUE | Cue Biopharma, Inc. | PASSERI DANIEL R | CEO, Dir | M - OptEx | — | +75.0K | 173.7K | +76% | — |
| D | 2021-10-08 | 2021-09-30 | CUE | Cue Biopharma, Inc. | PASSERI DANIEL R | CEO, Dir | F - Tax | $14.57 | -31.7K | 98.7K | -24% | -$461.5K |
| D | 2021-10-08 | 2021-09-30 | CUE | Cue Biopharma, Inc. | PASSERI DANIEL R | CEO, Dir | M - OptEx | — | +75.0K | 130.4K | +135% | — |
| 2021-09-27 | 2021-09-24 | CUE | Cue Biopharma, Inc. | PASSERI DANIEL R | CEO, Dir | P - Purchase | $14.72 | +3,400 | 55.4K | +7% | +$50.0K |
Purchase Sale Sale after option exercise All abbreviations